Click on any of the studies below to learn more about whether you might be eligible to participate and contact our research team.
A Phase I/II Randomized, Double-Blind, Placebo-Controlled Trial of Cannabidiol for Alcohol Use Disorder
The purpose of this research study is to see how safe and effective cannabidiol (CBD) is for the treatment of alcohol dependence. We also would like to assess its effects on thinking, behavior and habits of people with Alcohol Use disorder.
A Multi-Center Randomized Double-Blind Support-of-Concept Phase 2 Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)
The purpose of this research is to study the medical and safety effects of a single dose of an investigational drug called psilocybin compared to an active placebo in participants with Major Depressive Disorder (MDD) who are otherwise medically healthy.